Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Combining PRP with minoxidil significantly improves hair growth in AGA patients.

COVID-19 may cause hair loss due to infection stress or treatments.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

Children's screen time increased during the pandemic, causing various health issues.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Topical Minoxidil is effective for hair loss after COVID-19.

COVID-19 can cause temporary hair loss.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

COVID-19 can cause hair loss starting as early as 18 days after infection.

COVID-19 doesn't make alopecia areata worse.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.